Skip to main content

Table 1 Characteristics of the CHB patients at entry to the study*

From: Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients

Characteristics

All patients

(n = 55)

Sex (male/female)

42/13

Mean age (in years)

30.9 ± 8.5

Duration of infection (years)

13.8 ± 8.7

Serum ALT level (IU/L)

251.4 ± 66.1

Serum AST level (IU/L)

195.7 ± 81.6

Serum total bilirubin level (μmol/mL)

26.7 ± 18.1

Serum HBV DNA (copies/mL)

 

   > 1.0 × 105 ~ 1.0 × 107

10 (18.2)

   > 1.0 × 107

45 (81.8)

HBV DNA (Log, copies/mL)

7.9 ± 1.1

Diagnosis of chronic hepatitis (Histopathological results)

 

   Mild (grade 1–2, stage 0–2)

7 (12.7)

   Moderate (grade 3, stage 1–3)

40 (72.7)

   Severe (grade 4, stage 2–4)

8 (14.5)

  1. * CHB, chronic hepatitis B; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Normal values: ALT, ≤40 IU/L; AST, ≤40 IU/L; total bilirubin, ≤17.1 μmol/mL. † Date are expressed as mean ± SD; ‡ Data are expressed as no. (%).